Navigating Relapse and Sequencing Treatment After BTK Inhibitors in MCL
Peter Martin, MD, discusses the complexities of treating relapsed MCL after treatment with a BTK inhibitor.
Previous Post
STAT+: Supreme Court lets Trump slash NIH research funds
Next Post
#VisualAbstract: Vepdegestrant Increased Progres-sion-Free Survival in Advaced Breast 2m TM Cancer with ESR1 Mutations
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago